nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP2C9—Ifosfamide—testicular cancer	0.0764	0.253	CbGbCtD
Estropipate—ESR2—seminiferous tubule of testis—testicular cancer	0.0671	0.301	CbGeAlD
Estropipate—SHBG—seminiferous tubule of testis—testicular cancer	0.0653	0.292	CbGeAlD
Estropipate—ALB—Methotrexate—testicular cancer	0.0448	0.148	CbGbCtD
Estropipate—CYP3A4—Ifosfamide—testicular cancer	0.0444	0.147	CbGbCtD
Estropipate—CYP1A2—Etoposide—testicular cancer	0.0405	0.134	CbGbCtD
Estropipate—CYP2C9—Cisplatin—testicular cancer	0.0372	0.123	CbGbCtD
Estropipate—SHBG—semen—testicular cancer	0.0361	0.162	CbGeAlD
Estropipate—CYP3A4—Vinblastine—testicular cancer	0.0236	0.0779	CbGbCtD
Estropipate—CYP3A4—Etoposide—testicular cancer	0.0212	0.0702	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—testicular cancer	0.0145	0.0479	CbGbCtD
Estropipate—ESR1—embryo—testicular cancer	0.00574	0.0257	CbGeAlD
Estropipate—ESR2—gonad—testicular cancer	0.00569	0.0255	CbGeAlD
Estropipate—SHBG—gonad—testicular cancer	0.00553	0.0248	CbGeAlD
Estropipate—ESR2—female gonad—testicular cancer	0.00462	0.0207	CbGeAlD
Estropipate—SHBG—female gonad—testicular cancer	0.00449	0.0201	CbGeAlD
Estropipate—ESR2—testis—testicular cancer	0.0041	0.0184	CbGeAlD
Estropipate—SHBG—testis—testicular cancer	0.00398	0.0179	CbGeAlD
Estropipate—ESR1—gonad—testicular cancer	0.00389	0.0175	CbGeAlD
Estropipate—ALB—testis—testicular cancer	0.00329	0.0147	CbGeAlD
Estropipate—ESR1—female gonad—testicular cancer	0.00317	0.0142	CbGeAlD
Estropipate—ESR2—lymph node—testicular cancer	0.00297	0.0133	CbGeAlD
Estropipate—ESR1—testis—testicular cancer	0.00281	0.0126	CbGeAlD
Estropipate—ALB—lymph node—testicular cancer	0.00239	0.0107	CbGeAlD
Estropipate—ESR1—lymph node—testicular cancer	0.00203	0.00912	CbGeAlD
Estropipate—Nausea—Vinblastine—testicular cancer	0.000587	0.00124	CcSEcCtD
Estropipate—Migraine—Doxorubicin—testicular cancer	0.000586	0.00123	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000584	0.00123	CcSEcCtD
Estropipate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000584	0.00123	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—testicular cancer	0.000582	0.00123	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—testicular cancer	0.000581	0.00123	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—testicular cancer	0.000574	0.00121	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—testicular cancer	0.000569	0.0012	CcSEcCtD
Estropipate—Urticaria—Ifosfamide—testicular cancer	0.000567	0.0012	CcSEcCtD
Estropipate—Body temperature increased—Ifosfamide—testicular cancer	0.000564	0.00119	CcSEcCtD
Estropipate—Abdominal pain—Ifosfamide—testicular cancer	0.000564	0.00119	CcSEcCtD
Estropipate—Anaphylactic shock—Etoposide—testicular cancer	0.000564	0.00119	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—testicular cancer	0.000564	0.00119	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000561	0.00118	CcSEcCtD
Estropipate—Infection—Etoposide—testicular cancer	0.00056	0.00118	CcSEcCtD
Estropipate—Abdominal distension—Epirubicin—testicular cancer	0.000559	0.00118	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—testicular cancer	0.000559	0.00118	CcSEcCtD
Estropipate—Influenza—Epirubicin—testicular cancer	0.000556	0.00117	CcSEcCtD
Estropipate—Asthma—Epirubicin—testicular cancer	0.000556	0.00117	CcSEcCtD
Estropipate—Dysuria—Methotrexate—testicular cancer	0.000555	0.00117	CcSEcCtD
Estropipate—Paraesthesia—Cisplatin—testicular cancer	0.000553	0.00117	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000552	0.00116	CcSEcCtD
Estropipate—Skin disorder—Etoposide—testicular cancer	0.000548	0.00115	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—testicular cancer	0.000545	0.00115	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—testicular cancer	0.000538	0.00113	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—testicular cancer	0.000533	0.00112	CcSEcCtD
Estropipate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000531	0.00112	CcSEcCtD
Estropipate—Vomiting—Bleomycin—testicular cancer	0.000531	0.00112	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—testicular cancer	0.000529	0.00112	CcSEcCtD
Estropipate—Infestation—Methotrexate—testicular cancer	0.000529	0.00112	CcSEcCtD
Estropipate—Depression—Methotrexate—testicular cancer	0.000528	0.00111	CcSEcCtD
Estropipate—Rash—Bleomycin—testicular cancer	0.000527	0.00111	CcSEcCtD
Estropipate—Pain—Cisplatin—testicular cancer	0.000526	0.00111	CcSEcCtD
Estropipate—Dermatitis—Bleomycin—testicular cancer	0.000526	0.00111	CcSEcCtD
Estropipate—Hypersensitivity—Ifosfamide—testicular cancer	0.000526	0.00111	CcSEcCtD
Estropipate—Dysuria—Epirubicin—testicular cancer	0.00052	0.0011	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—testicular cancer	0.000518	0.00109	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000516	0.00109	CcSEcCtD
Estropipate—Influenza—Doxorubicin—testicular cancer	0.000514	0.00108	CcSEcCtD
Estropipate—Asthma—Doxorubicin—testicular cancer	0.000514	0.00108	CcSEcCtD
Estropipate—Asthenia—Ifosfamide—testicular cancer	0.000512	0.00108	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—testicular cancer	0.000506	0.00107	CcSEcCtD
Estropipate—Weight increased—Epirubicin—testicular cancer	0.000506	0.00107	CcSEcCtD
Estropipate—Pruritus—Ifosfamide—testicular cancer	0.000505	0.00106	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—testicular cancer	0.000504	0.00106	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—testicular cancer	0.000501	0.00106	CcSEcCtD
Estropipate—Somnolence—Etoposide—testicular cancer	0.000501	0.00106	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—testicular cancer	0.000501	0.00106	CcSEcCtD
Estropipate—Nausea—Bleomycin—testicular cancer	0.000496	0.00105	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—testicular cancer	0.000495	0.00104	CcSEcCtD
Estropipate—Infestation—Epirubicin—testicular cancer	0.000495	0.00104	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—testicular cancer	0.000495	0.00104	CcSEcCtD
Estropipate—Rash—Dactinomycin—testicular cancer	0.000491	0.00104	CcSEcCtD
Estropipate—Diarrhoea—Ifosfamide—testicular cancer	0.000488	0.00103	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000487	0.00103	CcSEcCtD
Estropipate—Body temperature increased—Cisplatin—testicular cancer	0.000486	0.00103	CcSEcCtD
Estropipate—Fatigue—Etoposide—testicular cancer	0.000486	0.00102	CcSEcCtD
Estropipate—Neuropathy peripheral—Epirubicin—testicular cancer	0.000486	0.00102	CcSEcCtD
Estropipate—Pain—Etoposide—testicular cancer	0.000482	0.00102	CcSEcCtD
Estropipate—Constipation—Etoposide—testicular cancer	0.000482	0.00102	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—testicular cancer	0.000481	0.00101	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000478	0.00101	CcSEcCtD
Estropipate—Dizziness—Ifosfamide—testicular cancer	0.000472	0.000995	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—testicular cancer	0.000472	0.000995	CcSEcCtD
Estropipate—Hepatobiliary disease—Epirubicin—testicular cancer	0.000469	0.000988	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—testicular cancer	0.000468	0.000987	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—testicular cancer	0.000465	0.00098	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—testicular cancer	0.000464	0.000978	CcSEcCtD
Estropipate—Nausea—Dactinomycin—testicular cancer	0.000463	0.000976	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—testicular cancer	0.000461	0.000972	CcSEcCtD
Estropipate—Infestation—Doxorubicin—testicular cancer	0.000458	0.000967	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—testicular cancer	0.000458	0.000967	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—testicular cancer	0.000458	0.000966	CcSEcCtD
Estropipate—Vomiting—Ifosfamide—testicular cancer	0.000454	0.000957	CcSEcCtD
Estropipate—Hypersensitivity—Cisplatin—testicular cancer	0.000453	0.000956	CcSEcCtD
Estropipate—Rash—Ifosfamide—testicular cancer	0.00045	0.000949	CcSEcCtD
Estropipate—Dermatitis—Ifosfamide—testicular cancer	0.00045	0.000948	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—testicular cancer	0.000449	0.000948	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000449	0.000948	CcSEcCtD
Estropipate—Urticaria—Etoposide—testicular cancer	0.000448	0.000944	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—testicular cancer	0.000446	0.00094	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—testicular cancer	0.000446	0.00094	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—testicular cancer	0.000446	0.00094	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—testicular cancer	0.000444	0.000937	CcSEcCtD
Estropipate—Asthenia—Cisplatin—testicular cancer	0.000441	0.000931	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—testicular cancer	0.000441	0.000931	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—testicular cancer	0.000441	0.00093	CcSEcCtD
Estropipate—Oedema peripheral—Epirubicin—testicular cancer	0.000438	0.000924	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000434	0.000914	CcSEcCtD
Estropipate—Angiopathy—Methotrexate—testicular cancer	0.000431	0.000909	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—testicular cancer	0.00043	0.000907	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—testicular cancer	0.000429	0.000905	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—testicular cancer	0.000429	0.000904	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—testicular cancer	0.000428	0.000903	CcSEcCtD
Estropipate—Nausea—Ifosfamide—testicular cancer	0.000424	0.000894	CcSEcCtD
Estropipate—Diarrhoea—Cisplatin—testicular cancer	0.000421	0.000888	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—testicular cancer	0.000421	0.000887	CcSEcCtD
Estropipate—Alopecia—Methotrexate—testicular cancer	0.00042	0.000886	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—testicular cancer	0.000416	0.000878	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—testicular cancer	0.000416	0.000877	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—testicular cancer	0.000415	0.000876	CcSEcCtD
Estropipate—Erythema—Methotrexate—testicular cancer	0.000414	0.000872	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—testicular cancer	0.000414	0.000872	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—testicular cancer	0.000413	0.00087	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—testicular cancer	0.000413	0.00087	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—testicular cancer	0.000408	0.000861	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—testicular cancer	0.000405	0.000855	CcSEcCtD
Estropipate—Asthenia—Etoposide—testicular cancer	0.000404	0.000853	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—testicular cancer	0.000404	0.000851	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—testicular cancer	0.000402	0.000847	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—testicular cancer	0.000401	0.000845	CcSEcCtD
Estropipate—Back pain—Methotrexate—testicular cancer	0.0004	0.000844	CcSEcCtD
Estropipate—Pruritus—Etoposide—testicular cancer	0.000399	0.000841	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—testicular cancer	0.000397	0.000836	CcSEcCtD
Estropipate—Alopecia—Epirubicin—testicular cancer	0.000393	0.000829	CcSEcCtD
Estropipate—Vomiting—Cisplatin—testicular cancer	0.000391	0.000825	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—testicular cancer	0.00039	0.000822	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—testicular cancer	0.000389	0.000821	CcSEcCtD
Estropipate—Rash—Cisplatin—testicular cancer	0.000388	0.000818	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—testicular cancer	0.000388	0.000817	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—testicular cancer	0.000387	0.000816	CcSEcCtD
Estropipate—Erythema—Epirubicin—testicular cancer	0.000387	0.000816	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—testicular cancer	0.000386	0.000813	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—testicular cancer	0.000385	0.000811	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—testicular cancer	0.000382	0.000805	CcSEcCtD
Estropipate—Flatulence—Epirubicin—testicular cancer	0.000382	0.000805	CcSEcCtD
Estropipate—Tension—Epirubicin—testicular cancer	0.00038	0.000801	CcSEcCtD
Estropipate—Nervousness—Epirubicin—testicular cancer	0.000376	0.000793	CcSEcCtD
Estropipate—Back pain—Epirubicin—testicular cancer	0.000375	0.00079	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—testicular cancer	0.000373	0.000787	CcSEcCtD
Estropipate—Dizziness—Etoposide—testicular cancer	0.000373	0.000786	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—testicular cancer	0.000372	0.000785	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—testicular cancer	0.000372	0.000784	CcSEcCtD
Estropipate—Vertigo—Methotrexate—testicular cancer	0.000372	0.000784	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000371	0.000782	CcSEcCtD
Estropipate—Nausea—Cisplatin—testicular cancer	0.000365	0.000771	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—testicular cancer	0.000364	0.000767	CcSEcCtD
Estropipate—Cough—Methotrexate—testicular cancer	0.000361	0.000761	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—testicular cancer	0.000361	0.00076	CcSEcCtD
Estropipate—Vomiting—Etoposide—testicular cancer	0.000358	0.000756	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—testicular cancer	0.000358	0.000755	CcSEcCtD
Estropipate—Erythema—Doxorubicin—testicular cancer	0.000358	0.000755	CcSEcCtD
Estropipate—Rash—Etoposide—testicular cancer	0.000355	0.00075	CcSEcCtD
Estropipate—Dermatitis—Etoposide—testicular cancer	0.000355	0.000749	CcSEcCtD
Estropipate—Headache—Etoposide—testicular cancer	0.000353	0.000745	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—testicular cancer	0.000353	0.000744	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—testicular cancer	0.000352	0.000743	CcSEcCtD
Estropipate—Myalgia—Methotrexate—testicular cancer	0.000352	0.000743	CcSEcCtD
Estropipate—Tension—Doxorubicin—testicular cancer	0.000352	0.000741	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00035	0.000738	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—testicular cancer	0.000348	0.000734	CcSEcCtD
Estropipate—Vertigo—Epirubicin—testicular cancer	0.000348	0.000734	CcSEcCtD
Estropipate—Back pain—Doxorubicin—testicular cancer	0.000347	0.000731	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—testicular cancer	0.000344	0.000726	CcSEcCtD
Estropipate—Palpitations—Epirubicin—testicular cancer	0.000342	0.000722	CcSEcCtD
Estropipate—Cough—Epirubicin—testicular cancer	0.000338	0.000712	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—testicular cancer	0.000338	0.000712	CcSEcCtD
Estropipate—Infection—Methotrexate—testicular cancer	0.000335	0.000707	CcSEcCtD
Estropipate—Nausea—Etoposide—testicular cancer	0.000335	0.000706	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—testicular cancer	0.000331	0.000698	CcSEcCtD
Estropipate—Myalgia—Epirubicin—testicular cancer	0.00033	0.000695	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—testicular cancer	0.00033	0.000695	CcSEcCtD
Estropipate—Anxiety—Epirubicin—testicular cancer	0.000328	0.000693	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—testicular cancer	0.000328	0.000692	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000327	0.00069	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—testicular cancer	0.000322	0.000679	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—testicular cancer	0.000317	0.000668	CcSEcCtD
Estropipate—Oedema—Epirubicin—testicular cancer	0.000316	0.000666	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—testicular cancer	0.000316	0.000666	CcSEcCtD
Estropipate—Infection—Epirubicin—testicular cancer	0.000314	0.000662	CcSEcCtD
Estropipate—Cough—Doxorubicin—testicular cancer	0.000313	0.000659	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—testicular cancer	0.00031	0.000653	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000308	0.000649	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—testicular cancer	0.000307	0.000647	CcSEcCtD
Estropipate—Insomnia—Methotrexate—testicular cancer	0.000305	0.000644	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—testicular cancer	0.000305	0.000643	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—testicular cancer	0.000305	0.000643	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—testicular cancer	0.000304	0.000641	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—testicular cancer	0.000303	0.000639	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000303	0.000639	CcSEcCtD
Estropipate—Somnolence—Methotrexate—testicular cancer	0.0003	0.000633	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—testicular cancer	0.000297	0.000627	CcSEcCtD
Estropipate—Oedema—Doxorubicin—testicular cancer	0.000292	0.000617	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000292	0.000617	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000292	0.000615	CcSEcCtD
Estropipate—Fatigue—Methotrexate—testicular cancer	0.000291	0.000614	CcSEcCtD
Estropipate—Infection—Doxorubicin—testicular cancer	0.00029	0.000613	CcSEcCtD
Estropipate—Pain—Methotrexate—testicular cancer	0.000289	0.000609	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000288	0.000607	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—testicular cancer	0.000287	0.000605	CcSEcCtD
Estropipate—Insomnia—Epirubicin—testicular cancer	0.000286	0.000603	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—testicular cancer	0.000284	0.000599	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—testicular cancer	0.000284	0.000598	CcSEcCtD
Estropipate—Somnolence—Epirubicin—testicular cancer	0.000281	0.000592	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—testicular cancer	0.000278	0.000587	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000276	0.000582	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000273	0.000575	CcSEcCtD
Estropipate—Fatigue—Epirubicin—testicular cancer	0.000272	0.000574	CcSEcCtD
Estropipate—Pain—Epirubicin—testicular cancer	0.00027	0.00057	CcSEcCtD
Estropipate—Constipation—Epirubicin—testicular cancer	0.00027	0.00057	CcSEcCtD
Estropipate—Urticaria—Methotrexate—testicular cancer	0.000268	0.000566	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—testicular cancer	0.000267	0.000563	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—testicular cancer	0.000267	0.000563	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000266	0.000562	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—testicular cancer	0.000264	0.000558	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—testicular cancer	0.000263	0.000554	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—testicular cancer	0.00026	0.000548	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000258	0.000545	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—testicular cancer	0.000257	0.000543	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000252	0.000532	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—testicular cancer	0.000252	0.000532	CcSEcCtD
Estropipate—Urticaria—Epirubicin—testicular cancer	0.000251	0.000529	CcSEcCtD
Estropipate—Pain—Doxorubicin—testicular cancer	0.00025	0.000527	CcSEcCtD
Estropipate—Constipation—Doxorubicin—testicular cancer	0.00025	0.000527	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—testicular cancer	0.00025	0.000527	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—testicular cancer	0.00025	0.000527	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—testicular cancer	0.000249	0.000525	CcSEcCtD
Estropipate—Asthenia—Methotrexate—testicular cancer	0.000242	0.000511	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000239	0.000504	CcSEcCtD
Estropipate—Pruritus—Methotrexate—testicular cancer	0.000239	0.000504	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—testicular cancer	0.000233	0.000491	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—testicular cancer	0.000232	0.00049	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—testicular cancer	0.000231	0.000487	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—testicular cancer	0.000231	0.000487	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—testicular cancer	0.000231	0.000487	CcSEcCtD
Estropipate—Asthenia—Epirubicin—testicular cancer	0.000227	0.000478	CcSEcCtD
Estropipate—Pruritus—Epirubicin—testicular cancer	0.000224	0.000471	CcSEcCtD
Estropipate—Dizziness—Methotrexate—testicular cancer	0.000223	0.000471	CcSEcCtD
Estropipate—Diarrhoea—Epirubicin—testicular cancer	0.000216	0.000456	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—testicular cancer	0.000215	0.000454	CcSEcCtD
Estropipate—Vomiting—Methotrexate—testicular cancer	0.000215	0.000453	CcSEcCtD
Estropipate—Rash—Methotrexate—testicular cancer	0.000213	0.000449	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—testicular cancer	0.000213	0.000449	CcSEcCtD
Estropipate—Headache—Methotrexate—testicular cancer	0.000212	0.000446	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—testicular cancer	0.00021	0.000442	CcSEcCtD
Estropipate—Dizziness—Epirubicin—testicular cancer	0.000209	0.000441	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—testicular cancer	0.000207	0.000436	CcSEcCtD
Estropipate—Vomiting—Epirubicin—testicular cancer	0.000201	0.000424	CcSEcCtD
Estropipate—Nausea—Methotrexate—testicular cancer	0.000201	0.000423	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—testicular cancer	0.0002	0.000422	CcSEcCtD
Estropipate—Rash—Epirubicin—testicular cancer	0.000199	0.00042	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—testicular cancer	0.000199	0.00042	CcSEcCtD
Estropipate—Headache—Epirubicin—testicular cancer	0.000198	0.000417	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—testicular cancer	0.000193	0.000408	CcSEcCtD
Estropipate—Nausea—Epirubicin—testicular cancer	0.000188	0.000396	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—testicular cancer	0.000186	0.000392	CcSEcCtD
Estropipate—Rash—Doxorubicin—testicular cancer	0.000184	0.000389	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—testicular cancer	0.000184	0.000388	CcSEcCtD
Estropipate—Headache—Doxorubicin—testicular cancer	0.000183	0.000386	CcSEcCtD
Estropipate—Nausea—Doxorubicin—testicular cancer	0.000174	0.000366	CcSEcCtD
